Syros Pharmaceuticals Inc. buy BiotechBee
Start price
04.12.23
/
60%
€2.67
Target price
30.11.25
€4.00
Performance (%)
-43.45%
Price
29.08.24
€1.51
Summary
This prediction is currently active. Massive losses of -43.45% have been the result for the BUY prediction by BiotechBee. This prediction currently runs until 30.11.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Syros Pharmaceuticals Inc. | 2.721% | 2.721% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
According to BiotechBee what are the pros and cons of Syros Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Syros Pharmaceuticals Inc diskutieren
Buy mit Kursziel 4,0
Stopped prediction by BiotechBee for Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.68
24.06.23
24.06.23
€4.00
31.12.25
31.12.25
36.94%
01.10.23
01.10.23
Could be very worthwhile Investment >20% year